These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30847484)

  • 1. The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall.
    Ketelhuth DFJ
    Cardiovasc Res; 2019 Jul; 115(9):1408-1415. PubMed ID: 30847484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
    Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gisterå A; Assinger A; Laguna-Fernandez A; Bäck M; Hansson GK; Ketelhuth DF
    Cardiovasc Res; 2015 May; 106(2):295-302. PubMed ID: 25750192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field.
    Polyzos KA; Ketelhuth DF
    Hamostaseologie; 2015; 35(2):128-36. PubMed ID: 25599530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.
    Ketelhuth DFJ; Lutgens E; Bäck M; Binder CJ; Van den Bossche J; Daniel C; Dumitriu IE; Hoefer I; Libby P; O'Neill L; Weber C; Evans PC
    Cardiovasc Res; 2019 Jul; 115(9):1385-1392. PubMed ID: 31228191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis.
    Baumgartner R; Forteza MJ; Ketelhuth DFJ
    Cytokine; 2019 Oct; 122():154148. PubMed ID: 28899580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunometabolism orchestrates training of innate immunity in atherosclerosis.
    van Tuijl J; Joosten LAB; Netea MG; Bekkering S; Riksen NP
    Cardiovasc Res; 2019 Jul; 115(9):1416-1424. PubMed ID: 31050710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study.
    Niinisalo P; Oksala N; Levula M; Pelto-Huikko M; Järvinen O; Salenius JP; Kytömäki L; Soini JT; Kähönen M; Laaksonen R; Hurme M; Lehtimäki T
    Ann Med; 2010; 42(1):55-63. PubMed ID: 19941414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
    Harden JL; Egilmez NK
    Immunol Invest; 2012; 41(6-7):738-64. PubMed ID: 23017144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease.
    Wongpraparut N; Pengchata P; Piyophirapong S; Panchavinnin P; Pongakasira R; Arechep N; Kasetsinsombat K; Maneechotesuwan K
    BMC Cardiovasc Disord; 2021 Jul; 21(1):353. PubMed ID: 34311709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines.
    MacKenzie CR; Heseler K; Müller A; Däubener W
    Curr Drug Metab; 2007 Apr; 8(3):237-44. PubMed ID: 17430112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications.
    Liu G; Chen S; Zhong J; Teng K; Yin Y
    Oxid Med Cell Longev; 2017; 2017():1602074. PubMed ID: 28377795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan Metabolism in Atherosclerosis and Diabetes.
    Sudar-Milovanovic E; Gluvic Z; Obradovic M; Zaric B; Isenovic ER
    Curr Med Chem; 2022; 29(1):99-113. PubMed ID: 34269660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
    Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
    Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
    Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
    Front Immunol; 2018; 9():950. PubMed ID: 29867939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDO: a double-edged sword for T(H)1/T(H)2 regulation.
    Xu H; Zhang GX; Ciric B; Rostami A
    Immunol Lett; 2008 Nov; 121(1):1-6. PubMed ID: 18824197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
    Cole JE; Astola N; Cribbs AP; Goddard ME; Park I; Green P; Davies AH; Williams RO; Feldmann M; Monaco C
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13033-8. PubMed ID: 26438837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Drug Metab; 2007 Apr; 8(3):273-82. PubMed ID: 17430115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.